How Does RadNet Company Sell Its Products and Services?

RadNet targets primary care, OB/GYN, oncology, and orthopedic physicians who generate referrals; the firm emphasizes AI-assisted reads and fast turnaround to increase diagnostic certainty and referral retention.

Managed care organizations and hospital systems are pitched on cost-containment: outpatient imaging is presented as 30-60 percent cheaper than Hospital Outpatient Departments, a key RadNet sales strategy for managed services and contract wins.

Patients in the Sunbelt and dense urban clusters are targeted via convenient hub-and-spoke locations, online booking, and competitive out-of-pocket pricing for MRI, CT, and mammography services to drive direct-to-consumer volume.

RadNet pursues employer contracts and physician-group partnerships for employee imaging benefits and referral pipelines, leveraging teleradiology services and managed services agreements to scale.

RadNet positions as a value-driven, convenient outpatient imaging platform that blends cost savings with tech-enabled quality (AI-assisted reads and teleradiology) to outcompete in-hospital radiology services.

The proposition aligns with payer pressure to cut costs, referring physicians' demand for fast, accurate reads, and patient preference for convenience; RadNet's regional footprint and pricing model support scalable volume and referral retention.

RadNet primarily sells through a referral pipeline: physician orders and health system partnerships feed outpatient centers where on – site MRI, CT, PET and mammography are delivered. The model mixes enterprise contracts, hospital management agreements, and direct – to – consumer scheduling channels.

Revenue comes from fee – for – service imaging reimbursements, capitation/managed care payments, and ancillary service fees; RadNet also captures upsell value via bundled multi – modality visits and proprietary AI tools that command premium reimbursement or higher throughput.

Fast access, one – location multi – modality care, and strong referral relationships drive conversion; commercial insurance coverage and competitive pricing shorten patient decision cycles and boost utilization.

Repeat revenue stems from recurring screening programs (mammography), capitated contracts paying per member per month, and cross – sell of specialty imaging (PET/CT) plus teleradiology follow – ups that deepen account value.

Scale and brand reach from 11.5 million annual procedures and an expanding outpatient footprint support steady referral flow and pricing leverage; Digital Health ARR of $75.4 million at YE – 2025 adds recurring revenue that improves predictability.

RadNet's mix of direct – to – consumer imaging center marketing, physician referral partnerships, and managed services selling to hospitals and employers creates diversified acquisition channels; recent inorganic deals expand local market penetration quickly.

Medicare reimbursement volatility and payer mix shifts could pressure margins; integration risk from acquisitions and execution risk in scaling teleradiology and Digital Health products remain material.

Outlook is bullish for 2026: guidance targets 17-19% imaging revenue growth and EBITDA growth outpacing revenue, driven by platform scale, Digital Health ARR expansion, and targeted acquisitions that convert volume into scalable, tech-enabled revenue.